Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2025 年第 4 季持倉
持倉截至 2025/12/31，2026/2/13 申報。只含多頭部位，變化是跟 2025 年第 3 季比股數。
- 持股檔數
- 53
- 較 2025 年第 3 季 −3
- 總值
- $43.8 億
- 較 2025 年第 3 季 +$8.01 億 (+22.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| IMVTImmunovant, Inc. | COM | 11,526,971 | $2.93 億 | 6.7% | +1,798,126+18.5% | 加碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 2,800,000 | $2.86 億 | 6.5% | −1,354,086−32.6% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 4,111,782 | $2.86 億 | 6.5% | −104,029−2.5% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 3,004,034 | $2.46 億 | 5.6% | +4,034+0.1% | 加碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 15,726,349 | $2.42 億 | 5.5% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 3,336,998 | $2.12 億 | 4.8% | −963,002−22.4% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 1,150,000 | $2.10 億 | 4.8% | +250,000+27.8% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 7,750,000 | $1.95 億 | 4.4% | −250,382−3.1% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 4,000,000 | $1.85 億 | 4.2% | +1,000,000+33.3% | 加碼 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 4,246,440 | $1.76 億 | 4.0% | +297,530+7.5% | 加碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 2,821,135 | $1.43 億 | 3.3% | +2,821,135 | 新進 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 2,300,000 | $1.37 億 | 3.1% | +2,275,144+9,153.3% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 1,700,000 | $1.34 億 | 3.1% | −2,108,144−55.4% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 7,036,455 | $1.33 億 | 3.0% | +979,431+16.2% | 加碼 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 3,249,790 | $1.02 億 | 2.3% | +99,790+3.2% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 8,070,414 | $9,797 萬 | 2.2% | −3,861,723−32.4% | 減碼 | 歷史 |
| GRALGRAIL, Inc. | COM | 1,022,797 | $8,754 萬 | 2.0% | +1,022,797 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 2,524,833 | $7,857 萬 | 1.8% | −2,855,616−53.1% | 減碼 | 歷史 |
| LBRXLB Pharmaceuticals Inc | COM SHS | 3,352,804 | $7,463 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 2,003,978 | $6,956 萬 | 1.6% | +203,978+11.3% | 加碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 2,161,510 | $6,552 萬 | 1.5% | −493,271−18.6% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 810,142 | $6,197 萬 | 1.4% | −389,858−32.5% | 減碼 | 歷史 |
| CRMDCorMedix Inc. | COM | 5,274,076 | $6,134 萬 | 1.4% | +4,774,076+954.8% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 4,610,071 | $6,076 萬 | 1.4% | +4,610,071 | 新進 | 歷史 |
| ALKSAlkermes plc. | SHS | 2,000,000 | $5,596 萬 | 1.3% | +2,000,000 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,650,000 | $5,183 萬 | 1.2% | +650,000+32.5% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,900,738 | $5,162 萬 | 1.2% | −99,262−5.0% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 7,334,323 | $5,061 萬 | 1.2% | −525,325−6.7% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,000,000 | $5,002 萬 | 1.1% | +2,000,000 | 新進 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 1,000,000 | $4,630 萬 | 1.1% | +1,000,000 | 新進 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 5,740,850 | $4,432 萬 | 1.0% | +5,740,850 | 新進 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 2,614,004 | $4,399 萬 | 1.0% | +187,347+7.7% | 加碼 | 歷史 |
| GERNGeron Corp | COM | 32,511,271 | $4,291 萬 | 1.0% | −8,585,251−20.9% | 減碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 4,377,572 | $3,953 萬 | 0.9% | +2,138,219+95.5% | 加碼 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 477,684 | $3,771 萬 | 0.9% | +27,684+6.2% | 加碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 769,048 | $3,107 萬 | 0.7% | −6,725,952−89.7% | 減碼 | 歷史 |
| ENTAEnanta Pharmaceuticals Inc | COM | 1,956,867 | $3,086 萬 | 0.7% | +1,956,867 | 新進 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 1,676,540 | $2,245 萬 | 0.5% | +176,540+11.8% | 加碼 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 2,454,562 | $2,175 萬 | 0.5% | +1,000,000+68.7% | 加碼 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 5,013,661 | $2,005 萬 | 0.5% | +3,891,177+346.7% | 加碼 | 歷史 |
| ATAIAtai Beckley N.V. | SHS | 4,677,289 | $1,913 萬 | 0.4% | +4,677,289 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 366,435 | $1,642 萬 | 0.4% | −833,565−69.5% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 453,102 | $1,609 萬 | 0.4% | +453,102 | 新進 | 歷史 |
| HELPCybin Inc. | COM NEW | 1,854,255 | $1,517 萬 | 0.3% | +854,255+85.4% | 加碼 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $1,091 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MNPRMonopar Therapeutics | COM NEW | 95,408 | $623.0 萬 | 0.1% | +95,408 | 新進 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 453,686 | $538.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM NEW | 444,110 | $413.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BLLNBillionToOne, Inc. | CL A | 50,000 | $409.2 萬 | 0.1% | +50,000 | 新進 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 110,448 | $374.1 萬 | 0.1% | −640,974−85.3% | 減碼 | 歷史 |
| IVAInventiva S.A. | ADS | 490,000 | $227.8 萬 | 0.1% | +490,000 | 新進 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 89,589 | $123.6 萬 | <0.1% | +89,589 | 新進 | 歷史 |
| ANLAdlai Nortye Group Ltd. | ADS | 34,852 | $4.95 萬 | <0.1% | +34,852 | 新進 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $12.2 億 | – |
| BHVNBiohaven Ltd. | COM | – | $564.5 萬 |
2025 年第 3 季之後清倉（18 檔）
2025 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 3 季股數 | 2025 年第 3 季市值 | 2025 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| AKROAkero Therapeutics, Inc. | COM | 4,000,978 | $1.90 億 | 5.3% | 歷史 |
| ETNB89bio, Inc. | COM | 9,356,171 | $1.38 億 | 3.8% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 1,715,691 | $1.14 億 | 3.2% | 歷史 |
| EXASExact Sciences Corp | COM | 1,000,000 | $5,471 萬 | 1.5% | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,470,172 | $3,397 萬 | 0.9% | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM NEW | 300,000 | $2,873 萬 | 0.8% | 歷史 |
| QUREuniQure N.V. | SHS | 483,092 | $2,820 萬 | 0.8% | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 2,279,892 | $1,968 萬 | 0.5% | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 1,250,000 | $1,788 萬 | 0.5% | 歷史 |
| GMABGenmab A/S | SPONSORED ADS | 481,267 | $1,476 萬 | 0.4% | 歷史 |
| IMAImageneBio, Inc. | COM | 878,516 | $716.0 萬 | 0.2% | 歷史 |
| XNCRXencor Inc | COM | 549,439 | $644.5 萬 | 0.2% | 歷史 |
| PEPGPepGen Inc. | COM | 1,200,000 | $554.4 萬 | 0.2% | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 2,568,613 | $418.7 萬 | 0.1% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 105,085 | $224.3 萬 | 0.1% | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 144,600 | $183.8 萬 | 0.1% | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 259,014 | $112.2 萬 | <0.1% | 歷史 |
| CLYMClimb Bio, Inc. | COM | 509,789 | $102.5 萬 | <0.1% | 歷史 |